FMP
NASDAQ
2.86 USD
0.19 (6.64%)
Dr. William V. Williams M.D.
Healthcare
Biotechnology
https://www.briacell.com
NASDAQ
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
0001610820
CA1079301091
10778Y302
Bellevue Centre
604 921 1810
CA
16
Mar 14, 2012